NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
Back to search
Official data from USPTO
FORTREA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FORTREA
ST13
US500000097779230Class
35, 42, 44
Filing
97779230
Registration
8188092
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/25/2026
Trademark type
Word
Nice classes
35, 42, 44
Filing date
02/03/2023
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
02/09/2023
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
DURHAM, NC, US
Examiner
DIGAN, MATTHEW M
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
FORTREA INC.
Labcorp Drug Development Inc.
Representatives
Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consultingmanagementplanning services in the field of clinical trials; regulatory submission managementassisting others in preparing and filing applications with governmental regulatory bodies for approval and post-approval actions related to drugs and medical devices; economic forecasting and analysis in the field of pharmaceuticalbiotechnologymedical device industries; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; business management servicessupply and demand forecasting in connection with drug supplies for clinical trials; recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients and volunteers for participation in clinical trials for the testing of drugs; business administration of patient reimbursement programs; business advisory servicesbusiness consultancy servicesbusiness data analysisbusiness information servicesbusiness management consultingbusiness strategy development servicesmarket intelligence servicesmarket researchmarketing serviceselectronic data collection and data submission services for business purposesdatabase managementbusiness project management services all in the fields of clinical trials and post approval pharmaceuticalsmedical devicesbiotechnology; market research and business marketing consulting services in the fields of international health and pharmaceuticalbiotechnologymedical device industries; market analysis in the field of international health and in the pharmaceuticalbiotechnologymedical device industries; providing business and statistical information for business purposes and data processing servicesall in the field of international health and in the pharmaceuticalbiotechnologymedical device industries
Class 42
Pharmaceutical drug development services; design and testing of new productsmedical devicesfor others; research and development in the fields of pharmaceuticalsmedical devicesbiotechnology; medical and scientific research in the field of clinical trialsdesigningorganizingconductingmonitoringmanaging clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of designplanningimplementation project management of clinical trials and studies on pharmaceuticals and medical devices; providing temporary use of online non-downloadable software for the collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; database design and development in the field of pharmaceutical drug development and medical device testing services; design and development of software for use in conducting research in pharmaceutical and medical device development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnology; data mining in the fields of research and development of pharmaceuticalsmedical devicesbiotechnology; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical trials and studies on pharmaceuticals and medical devices; advisory services for others in the field of pharmaceutical drug development; providing medical and scientific research information in the fields of biochemistrypharmaceuticals and clinical trials; providing online non-downloadable software for trackingmonitoringanalyzinggenerating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; application service provider (ASP) featuring software for use in database and record management in the fields of clinical trials and post-approval research for pharmaceuticals and medical devices; providing temporary use of online non downloadable software for collectingorganizingreporting clinical trial information and trial results; providing temporary use of online non-downloadable software for uploading and accessing test results in the field of medical testing for scientific research purposes; providing temporary use of online non-downloadable software for storingretrievingaccessingdisplayingmanaginganalyzingreviewing information and data in the fields of pharmaceuticalsmedical devicesbiotechnology; scientific study and research in the field of production of pharmaceuticals and medical devices; providing online non-downloadable software for planningmanaging and supporting clinical trials; medical and scientific clinical research for others in the field of the production of pharmaceuticalsbiopharmaceuticalsmedical devices; software as a service (SAAS) serviceshosting software for use by others for the collectionreviewanalysisreporting of clinical trial and drug development information; research and development in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesmedical diagnostics; clinical research in the field of production of pharmaceuticalsmedical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collectreviewanalyze and report on clinical research and drug development information; providing temporary use of online non downloadable software to allow users to collectreviewanalyze and report on clinical research and drug development
Class 44
Medical services in the field of pharmacology and specimen collection and procedures in connection with clinical trials; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring medical information in the fields of clinical trials and patient management and outcomes; medical and pharmaceutical consultation
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2026
IULN
ITU LETTER MAILED, NO RESPONSE REQUIRED
03/02/2026
EEXT
SOU TEAS EXTENSION RECEIVED
01/23/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/24/2025
IUAF
USE AMENDMENT FILED
07/23/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/23/2025
EX2G
SOU EXTENSION 2 GRANTED
07/23/2025
EXT2
SOU EXTENSION 2 FILED
07/23/2025
EEXT
SOU TEAS EXTENSION RECEIVED
07/23/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX1G
SOU EXTENSION 1 GRANTED
01/23/2025
EXT1
SOU EXTENSION 1 FILED
01/23/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/23/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/19/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/19/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/19/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/19/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2023
GNRT
NON-FINAL ACTION E-MAILED
11/09/2023
CNRT
NON-FINAL ACTION WRITTEN
11/09/2023
DOCK
ASSIGNED TO EXAMINER
11/02/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2023
NWAP
NEW APPLICATION ENTERED
02/07/2023
Continuous trademark protection
Get notified about every new filing that threatens FORTREA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.